New Mechanisms in Glucose Control presents a clear overview of the
new drugs and treatment therapies that have been developed in
recent years to help improve glycaemic management for the diabetic
patient, namely the incretin mimetics (GLP-1 agonists) and DPP-4
inhibitors. It also considers other drug classes currently in
development and undergoing clinical trials including the SGLT2
inhibitors and other pipeline products. In addition to pharma
cotherapeutic agents, the role of bariatric as a management tool
for diabetes is covered as well as consideration of the
organisation of diabetes care with a community focus. This
indispensable pocketbook details the newer treatments and offers a
comparison with more traditional agents including sulphonyureas,
glitazones and insulin. The pros and cons of traditional therapies
are discussed as well as the epidemiology and pathogenesis of type
2 diabetes, helping to give the reader a better understanding of
the disease area and its management. New Mechanisms in Glucose
Control is essential reading for health professionals working in
primary or secondary care and involved in treating diabetic
patients.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!